SARS‐CoV‐2 infection in hematological patients during allogenic stem cell transplantation: A double case report | Zendy

Alexandra Van Uytvanck | Zendy; Sebastian Wittnebel | Zendy; Nathalie Meuleman | Zendy; Angela Loizidou | Zendy; JeanCorentin Salengros | Zendy; Chloé Spilleboudt | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

SARS‐CoV‐2 infection in hematological patients during allogenic stem cell transplantation: A double case report

Author(s) -

Alexandra Van Uytvanck,

Sebastian Wittnebel,

Nathalie Meuleman,

Angela Loizidou,

JeanCorentin Salengros,

Chloé Spilleboudt

Publication year - 2021

Publication title -

clinical case reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.21

H-Index - 9

ISSN - 2050-0904

DOI - 10.1002/ccr3.4439

Subject(s) - medicine , immunosuppression , myeloid leukemia , transplantation , hematopoietic stem cell transplantation , covid-19 , stem cell , leukemia , immunology , intensive care medicine , disease , infectious disease (medical specialty) , biology , genetics

Despite severe immunosuppression due to conditioning chemotherapy for acute myeloid leukemia, COVID‐19 did not lead to clinical deterioration or death, thus raising the question of the impact of immunosuppressive treatment on clinical course evolution.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research